Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.
Discover how modern lab automation mirrors enterprise robotics and AI. We explore practical use cases, benefits, and key ...
CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...
Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can ...
ON AN OCTOBER night in 1989, a 4-year-old girl was shocked awake by a phone ringing and then a scream. She crept out of her bedroom and tiptoed barefoot along the hallway’s clammy vinyl tile, ...
Launched less than three years ago, the system may be changing how point-of-care tests are used in doctor's offices and emergency rooms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results